Top Markets
Coin of the day
Abliva AB (publ) Abliva AB (publ)

Abliva AB (publ)

ABLI
Clasificación en acciones #22998
Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000,... Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000, focuses on developing innovative therapeutic solutions for primary mitochondrial diseases. Its pipeline includes KL1333, currently in Phase 2/3 clinical trials for the long-term management of these conditions, and NV354, which is preparing for clinical studies targeting primary mitochondrial diseases specifically linked to Complex I deficiency. The company is also advancing NeuroSTAT through a Phase 1b/2a clinical study for the treatment of traumatic brain injury. Abliva maintains strategic partnerships with entities such as Isomerase, Yungjin Pharm, the University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The firm rebranded as Abliva AB (publ) in May 2020, having previously been known as NeuroVive Pharmaceutical AB (publ).
Precio por acción
$0.04959193
Última sincronización: 2025-03-17
Capitalización bursátil
$79.94M
Cambio (1 día)
13.49%
Cambio (1 año)
0.00%
País
SE
Comercio Abliva AB (publ) (ABLI)

Categoría

Historial de desdoblamientos de acciones de Abliva AB (publ) (ABLI)
La acción Abliva AB (publ) (símbolo: ABLI) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 22, 2026.
Una acción ABLI comprada antes de Aug 22, 2026 equivaldría hoy a 0 acciones ABLI.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH